CNTB
Connect Biopharma Holdings Limited - Ordinary Shares (CNTB)
$28
About Connect Biopharma Holdings Limited - Ordinary Shares (CNTB)
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.
Details
Daily high
$1.32
Daily low
$1.25
Price at open
--
52 Week High
$3.82
52 Week Low
$1.06
Market cap
80.6M
Dividend yield
-
Volume
1,951
Avg. volume
2.0M
P/E ratio
-1.07
Connect Biopharma Holdings Limited - Ordinary Shares News
Details
Daily high
$1.32
Daily low
$1.25
Price at open
--
52 Week High
$3.82
52 Week Low
$1.06
Market cap
80.6M
Dividend yield
-
Volume
1,951
Avg. volume
2.0M
P/E ratio
-1.07